Hybrid Exercise Program for Heart Disease: Effect on Health and Quality of Life

NANot yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2026

Conditions
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Interventions
OTHER

Hybrid Endurance Strength Training

HybEST will be delivered three times weekly over eight weeks, with two supervised sessions at the center and 22 unsupervised sessions at home. The exercise characteristics of supervised HybEST and unsupervised HybEST are described. Monitoring methods for unsupervised HybEST include a wearable tracking device that collects data on patients' health parameters (arterial oxygen saturation (SpO2), heart rate, and blood pressure) and weekly phone calls. The unsupervised sessions will include video material on the home-based exercise program.

OTHER

Usual Care

The UC group participants will participate in combined endurance and strength training similar to the intervention group's weekly center-based session over eight weeks.

Trial Locations (1)

59100

Universiti Malaya Medical Center, Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT07130045 - Hybrid Exercise Program for Heart Disease: Effect on Health and Quality of Life | Biotech Hunter | Biotech Hunter